首页> 美国卫生研究院文献>Lipids in Health and Disease >Biopharmaceutical insights of particulate emulsified systems - a prospective overview
【2h】

Biopharmaceutical insights of particulate emulsified systems - a prospective overview

机译:颗粒乳化系统的生物制药见解-前瞻性概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During the twenty-first century, drug discovery is expanding rapidly and a large number of chemical moieties are recognized. Many of them are poorly soluble and hence related biopharmaceutical constraints are to be addressed systematically. Among novel approaches to resolving biopharmaceutical issues, micro- and nano-emulsified systems serve as the best strategy for delivering both hydrophobic and hydrophilic drugs owing to their greater solubilization and transportation capabilities. Of late, the unique physical and biopharmaceutical properties of these liquid isotropic homogenous systems have gained substantive research importance. In addition nano/micro lipid systems share structural and functional similarity with that of the physiological lipids which offer better tolerance ability in the body. In this context, this article provides information on the historical emergence of particulate emulsified systems, importance and rationale of selection of carriers. It also encompasses the physicochemical principles that are responsible for the elevation of therapeutic outcomes of delivery systems. Detailed and schematic absorption of these drug delivery systems is explained here. Gastro-intestinal biochemistry necessary in the understanding of digestion process, lipolytic products formed, micellar structures, enzymes, transporters, mechanism of cell uptake involved after subsequent oral absorption are also emphasized. In addition, this article also explains disposition and pharmacokinetic properties of emulsified systems with real-time therapeutic research outcomes. The influence of biochemical compositions and biopharmaceutical principles on absorption and disposition patterns of ME/NEs was described in the article for the interest of readers and young researchers.
机译:在二十一世纪,药物的发现正在迅速扩展,并认识到许多化学部分。它们中的许多溶解性差,因此需要系统地解决相关的生物药物限制。在解决生物制药问题的新方法中,微乳和纳米乳化系统由于具有更大的增溶和转运功能,因此成为输送疏水性和亲水性药物的最佳策略。最近,这些液体各向同性均质系统的独特物理和生物药物特性已获得了实质性的研究重要性。另外,纳米/微脂质系统与生理脂质具有相同的结构和功能相似性,在体内具有更好的耐受能力。在这种情况下,本文提供了有关颗粒乳化系统的历史出现,载体选择的重要性和原理的信息。它还涵盖了负责提高输送系统治疗效果的物理化学原理。这些药物输送系统的详细示意图吸收将在此进行说明。还强调了消化过程中必需的胃肠道生物化学,脂解产物的形成,胶束结构,酶,转运蛋白以及随后口服吸收后细胞吸收的机制。此外,本文还介绍了具有实时治疗研究成果的乳化系统的配置和药代动力学特性。在文章中描述了生化成分和生物制药原理对ME / NEs吸收和处置方式的影响,以引起读者和年轻研究人员的兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号